Overview
Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery
Status:
Completed
Completed
Trial end date:
2019-10-02
2019-10-02
Target enrollment:
0
0
Participant gender:
All
All
Summary
Bleeding after thoracic surgery is a major cause of perioperative hemodynamic instability and transfusion requirement, which can lead to a rise of morbidity, mortality and costs. The objective of this study is to evaluate the efficiency of tranexamic acid (TA) in the prevention of perioperative bleeding in thoracic hemorrhagic surgery.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University Tunis El ManarTreatments:
Tranexamic Acid
Criteria
Inclusion Criteria:- over the age of 18 years old, programmed for potentially hemorrhagic thoracic surgery,
such as pulmonary resection for aspergilloma, pulmonary tuberculosis, pleural
decortication, lobectomy with parietectomy or redux.
Exclusion Criteria:
- Patients who have had a major complication of surgery other than bleeding requiring
revision within 24 hours or a complication related to anesthesia, and cases of
non-compliance with the anesthetic protocol are excluded.